Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Rutherrin

<< Previous

Bullboard Posts

Next >>

Comment by patience69on Apr 16, 2022 1:18pm

178 Views

Post# 34607625

RE:RE:RE:Rutherrin

Laser
I certainly see your point in how the market cao has not increased in that long time frame. My point albeit right or wrong is that has the value of the company to say Merck or Roche etc increased with the progress on the trial? Increased in a way not reflected in stock value as we get closer to BTD & possible approval?

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing